StockDriftsStockDriftsTop 23 Novo Holdings A S Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| EWTX | EDGEWISE THERAPEUTICS INC | 12.62% | 5.35M | $217.4M | +0.00%(+0) | $29.70(+48.70%) | 2026-06-30 | |
| ASML | ASML HOLDING N V | 10.97% | 94.9K | $188.9M | +0.00%(+0) | $726.18(+157.20%) | 2026-06-30 | |
| BN | BROOKFIELD CORP | 8.68% | 3.50M | $149.5M | +0.00%(+0) | $21.64(+99.95%) | 2026-06-30 | |
| MPLT | MAPLIGHT THERAPEUTICS INC | 7.67% | 3.69M | $132.1M | +0.00%(+0) | $17.56(-33.11%) | 2026-06-30 | |
| MIRM | MIRUM PHARMACEUTICALS INC | 7.65% | 1.13M | $131.7M | -15.09%(-200.00K) | $13.54(+643.21%) | 2026-06-30 | |
| CRM | SALESFORCE INC | 3.58% | 393.2K | $61.6M | +0.00%(+0) | $218.84(-12.04%) | 2026-06-30 | |
| AVBP | ARRIVENT BIOPHARMA INC | 3.03% | 1.50M | $52.1M | -22.77%(-442.14K) | $18.93(+55.86%) | 2026-06-30 | |
| ELVN | ENLIVEN THERAPEUTICS INC | 2.95% | 1.00M | $50.8M | -21.88%(-280.00K) | $20.40(+188.33%) | 2026-06-30 | |
| CRNX | CRINETICS PHARMACEUTICALS IN | 2.87% | 1.32M | $49.4M | -14.84%(-230.00K) | $26.94(+214.36%) | 2026-06-30 | |
| PHVS | PHARVARIS N V | 2.81% | 1.40M | $48.4M | -20.00%(-350.00K) | $17.08(+105.78%) | 2026-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | +26.37% | +101.80% | +10.66% | +65.96% |
| Top 20 Holdings Unweighted | +23.85% | +89.97% | +5.14% | +28.46% |
Novo Holdings A S reports $1.72B in US-listed equity holdings across 25 positions in its most recent 13F filing. Its largest disclosed positions are EWTX (12.6%), ASML (11.0%) and BN (8.7%). The top 20 holdings account for 82.45% of reported assets. Its disclosed equity book has returned +101.80% on a three-year cumulative basis. Figures reflect the Q2 2026 filing.
Portfolio changes
Every reported change this quarter, grouped by direction. The signal is in the rotation, not any single trade.
Sign up free to track Novo Holdings A S, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Novo Holdings A S’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1388325). View Novo Holdings A S’s 13F filings on SEC